(Q41587406)

4 October 2017

1 reference

title

Classification and treatment of the juvenile idiopathic inflammatory myopathies (English)

1 reference

4 October 2017

1

1 reference

4 October 2017

2

1 reference

4 October 2017

publication date

1 August 1997

1 reference

Rheumatic Diseases Clinics of North America

4 October 2017

published in

1 reference

4 October 2017

volume

23

1 reference

4 October 2017

issue

3

1 reference

4 October 2017

page(s)

619-655

1 reference

Failure of first-line therapy with intravenous immunoglobulin in a child with scleromyositis

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Neuromuscular complications of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Eosinophilic myositis. An unusual cause of pseudotumor and eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Polymyositis in chronic graft vs host disease. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Eosinophilic Polymyositis Induced by Tranilast

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Myalgia and elevated creatine kinase activity associated with subcutaneous injections of diluent.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis (systemic angiopathy) of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Azathioprine therapy in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Localized scleroderma progressing to systemic disease. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

1 reference

7 January 2021

Early development of Hodgkin's lymphoma in association with the use of methotrexate for the treatment of dermatomyositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Efficacy of intravenous immunoglobulins in sclerodermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cyclophosphamide in severe polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Infantile myositis with leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis, polymyositis, and Coxsackie-B-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Plasma exchange therapy of a childhood onset dermatomyositis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Chronic orbital myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Prednisone and azathioprine for polymyositis: long-term followup.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Azathioprine with prednisone for polymyositis. A controlled, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Streptococcal myositis as a complication of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cutaneous photosensitivity in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Focal myositis of the thigh: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile dermatomyositis: treatment with intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

DERMATOMYOSITIS AND FOCAL SCLERODERMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis associated with idiopathic thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis after immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Diphosphonate Treatment of Calcinosis Universalis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile dermatomyositis treated with cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Plasmapheresis in childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of calcinosis circumscripta with probenecid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Diltiazem induces remission of calcinosis in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of dermatomyositis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Effects of pituitary adrenocorticotropic hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Focal myositis of the perioral musculature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Microvascular changes in early and advanced dermatomyositis: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Proliferative myositis.Report of thirty-three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Myositis in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Intracisternal collagen fibrils in proliferative fasciitis and myositis of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cyclosporine for juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cutaneous photosensitivity diseases induced by exogenous agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Inclusion body myositis and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis-like syndrome induced by nonsteroidal anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of polymyositis with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Vasculitis and myositis secondary to rubella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Orbital myositis: a study of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cyclosporin in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

1 reference

7 January 2021

Polymyositis and dermatomyositis 1990--diagnosis, treatment and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Absence of Coxsackie viruses in idiopathic inflammatory muscle disease by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Successful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Complications of Cyclosporin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Immunocytochemical and virological characteristics of hiv-associated inflammatory myopathies: Similarities with seronegative polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Focal myositis. A new cause for the pediatric neck mass

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Scleroderma/polymyositis overlap syndromes and their immunologic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

[Virus-like inclusions in chronic neuromuscular disorders. Electronmicroscopic findings of 2 cases]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Granulomatous myositis and muscle sarcoidosis. Clinical picture and biopsy histological diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis after B.C.G. vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Autoimmune disorders complicating adolescent hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Simvastatin-associated dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Antibody levels to parainfluenza, rubella, measles, and influenza a virus in children with polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood polymyositis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Successful treatment of dermatomyositis with dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of dermatomyositis with intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Pediatric onset of Behçet's syndrome with myositis: case report and literature review illustrating unusual features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Myopathy with ragged red fibres following renal transplantation: possible role of cyclosporin-induced hypomagnesaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Failure of warfarin in treatment of calcinosis universalis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Drug-induced myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood dermatomyositis associated with hepatocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile dermatomyositis in a child infected with human parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Noninfectious environmental agents associated with myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Management of fibrosing alveolitis with polymyositis dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of dermatomyositis with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment-resistant eosinophilic polymyositis in a child.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Inflammatory myopathies: Part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Inflammatory myopathies: Part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The first case of polymyositis associated with interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Proliferative fasciitis and myositis of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Surgical treatment of calcinosis cutis in the upper extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Long term follow-up of children with mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Late progression in dermatomyositis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood dermatomyositis. Clinical course and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Methotrexate treatment of recalcitrant childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Acute lymphoblastic leukemia associated with dermatomyositis in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Acute orbital myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Infantile polymyositis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of Calcinosis Universalis with Aluminium Hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Idiopathic recurrent non-suppurative focal myositis: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Neonatal perifascicular myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

T cell-mediated immune mechanisms in myositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile dermatomyositis: a clinical overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile dermatomyositis. Pathophysiology and disease expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of calcinosis with diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Polymyositis as a manifestation of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Anti-Ku antibodies in connective tissue diseases. Report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The oncogenicity of chlorambucil in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis responding to pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Renal haemodynamics of cyclosporin A nephrotoxicity in children with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Acute polymyositis associated with W. bancrofti

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Acute rectus muscle palsy in children as a result of orbital myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood onset inclusion body myositis mimicking limb-girdle muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Infantile myositis: a case diagnosed in the neonatal period

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Use of intravenous immune globulin in the therapy of children with rheumatological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Familial occurrence of dermatomyositis and progressive scleroderma after injection of a local anaesthetic for dental treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

[High dosage intravenous gamma globulin therapy in juvenile dermatomyositis]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile dermatomyositis induced by toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Orbital myositis with Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cervical focal myositis in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Surgical treatment of subcutaneous calcifications of polymyositis or dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Polymyositis after propylthiouracil treatment for hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Childhood polymyositis as a paraneoplastic phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Congenital inflammatory myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Acute myositis as an unusual presentation of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Mixed connective tissue disease in childhood. A clinical and serologic survey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Lymphocytic leukemia, atypical dermatomyositis, and hyperlipidemia in a 4-year-old boy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Chlorambucil. An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Idiopathic orbital myositis: report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Association of dermatomyositis and dysgerminoma in a 16-year-old patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Course of treated juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Orbital myositis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

DERMATOMYOSITIS, WITH REPORT OF A CASE WHICH PRESENTED A RARE MUSCLE ANOMALY BUT ONCE DESCRIBED IN MAN.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The red face: dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

A case of polymyositis associated with Kawasaki disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Polymyositis in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Juvenile-onset mixed connective tissue disease: longitudinal follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Hepatitis C infection and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Update on therapy for refractory dermatomyositis and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

The Inflammatory Myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Polymyositis, pulmonary fibrosis, and hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Inflammatory myopathy: a review of etiologic and pathogenetic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Mixed connective tissue disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Myositis associated with growth hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Orbital pseudotumor and Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

Treatment of dermatomyositis with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970350-1

7 January 2021

10.1016/S0889-857X(05)70350-1

Identifiers

DOI

1 reference

4 October 2017

1 reference